Agenda Topics- Biosimilar mAbs in US, Europe and Emerging Economies
- New Regulatory Requirements for Biosimilar Approval and Success in India
- Physical, Chemical and Biological Characterization and Similarity in Biologics
- Pre-clinical and Clinical Similarity
- US FDA Guidance and Regulatory Compliance for Biosimilars
Sponsorship and Exhibition OpportunitiesIra Sood, Exhibition Manager i.sood@selectbio.com 7696225050
|
Confirmed Speakers to dateShrivathsa Achar, Manager, Biocon Limited Anthony Crasto, Principal Scientist, Glenmark Generics Limited Ajaz Hussain, Consultant, Insight Advice & Solutions LLC Suresh Jadhav, Executive Director, Serum Institute of India Ltd Arvind Mishra, Joint President, Cadila Pharmaceuticals Ltd Arumugam Muruganandam, Mananging Director & Chief Scientific Officer, Affigenix Biosolutions Pvt Ltd Bharata Parayitam, Biotechnology Professional, Dr. Reddy’s Laboratories Ltd Sanjay Sonar, Director, BioGenomics Limited
|